Angelor is an independent French venture capital firm and 'société à mission' based in Lyon, investing in early-stage French startups with a focus on health, agri-food, environment, and technology. It channels capital and operational mentorship from a network of business leaders and experts to support innovative entrepreneurs.
33% of their portfolio is in Healthcare. They made 2 investments in the last 12 months.
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
HA
Henry Angleys
Investment Manager & Partner
SB
Sebastien Bonte
Président Fondateur
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Standing Ovation | Series B | $28.5M | Mar 2026 |
| DDillico | Seed | — | Jul 2025 |
| BBrenus Pharma | Series A | — | Jan 2024 |
 Mablink Bioscience | Series A | — | — |
 Pixee Medical | Unknown | $15M | — |
 Inalve | Unknown | — | — |
Top Co-Investors
UI Investissement5 shared
Bpifrance3 shared
Noshaq2 shared
Newtree Impact1 shared
Big Pi Ventures1 shared
Seventure Partners1 shared
Bel Group1 shared
Astanor1 shared
Danone Manifesto Ventures1 shared
Good Startup1 shared
Sofinnova Partners1 shared
Elaia1 shared
Innovacom1 shared
French Tech Seed Fund1 shared
Last updated: 8 September 2026